Women's Health
Implementing NK3 Antagonists in Clinical Practice
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2026-05-20
NK3 antagonists represent a novel treatment option for the management of vasomotor symptoms (VMS) associated with menopause. This program will review practical considerations for prescribing this new class of medications, including dosage, side effects, and monitoring requirements. By the end of the session, clinicians will be better equipped with the knowledge and confidence to integrate this treatment into practice when appropriate, using effective clinical decision-making.
This program has received an unrestricted educational grant or in-kind support from Astellas Pharma Canada Inc.
Faculty
- Chandi Chandrasena, MD, CCFP, FCFP
- Milan Atanackovic, MD
- Vivien Brown, MDCM, CCFP, FCFP, MSCP
- Marla Shapiro, MDCM, CCFP, MHSc, FRCP, FCFP, NCMP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe the role of personal preference in selecting a treatment for VMS
- Counsel patients on common side effects with NK3 antagonists
- Discuss appropriate monitoring strategies for NK3 antagonists
Accreditation
Accreditation Web This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 301106
#
of credits: 0.5
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Physician
Profession
0.5
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe the role of personal preference in selecting a treatment for VMS
- Counsel patients on common side effects with NK3 antagonists
- Discuss appropriate monitoring strategies for NK3 antagonists
Mainpro+
ACCREDITATION
Women's Health
Learning Category
Menopause
Topic
0
Price
2026-05-20
Expiry Date
CAN-eng
Region/Language
Course Description
NK3 antagonists represent a novel treatment option for the management of vasomotor symptoms (VMS) associated with menopause. This program will review practical considerations for prescribing this new class of medications, including dosage, side effects, and monitoring requirements. By the end of the session, clinicians will be better equipped with the knowledge and confidence to integrate this treatment into practice when appropriate, using effective clinical decision-making.
This program has received an unrestricted educational grant or in-kind support from Astellas Pharma Canada Inc.
Faculty
- Chandi Chandrasena, MD, CCFP, FCFP
- Milan Atanackovic, MD
- Vivien Brown, MDCM, CCFP, FCFP, MSCP
- Marla Shapiro, MDCM, CCFP, MHSc, FRCP, FCFP, NCMP
Accreditation
Accreditation Web
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 301106
30 min
Duration
0
Price
0.5
# of credits
